Mononuclear Ruthenium Complexes As Chemotherapeutic Agents - Anchuri, Shyam Sunder;Dhulipala, Satyavati
50,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
25 °P sammeln
  • Broschiertes Buch

Incorporation of biologically-active ligands into a metal (organo-metallic complexes) offers much scope for the design of novel therapeutic agents with enhanced targeted activity and new mode of action. Several ruthenium complexes have been reported to be promising biological activities. Here, some novel organometallic ruthenium (Ru) complexes, bearing thiosemicarbazone moieties were synthesized and screened for various pharmacological activities. It has been identified that the new Ru(II)-arene complexes demonstrating the validity of such an approach to the design of novel drugs in near future.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Incorporation of biologically-active ligands into a metal (organo-metallic complexes) offers much scope for the design of novel therapeutic agents with enhanced targeted activity and new mode of action. Several ruthenium complexes have been reported to be promising biological activities. Here, some novel organometallic ruthenium (Ru) complexes, bearing thiosemicarbazone moieties were synthesized and screened for various pharmacological activities. It has been identified that the new Ru(II)-arene complexes demonstrating the validity of such an approach to the design of novel drugs in near future.
Autorenporträt
Dr. Shyam Sunder Anchuri, Associate Professor & Head, Department of Pharmacology, S.R. College of Pharmacy, Ananthasagar, Warangal. He has 7 years of teaching and 5 years of research experience with 14 research publications in National and International Journals. He is a life member of Indian Pharmacological Society & Reviewer for various Journals.